Nonrelapse mortality after CAR T-cell therapy in large B-cell lymphoma: a systematic review and meta-analysis
• Non-relapse mortality after CAR T-cell therapy is a time-sensitive parameter indicating the relevance for follow-up adjustment • Both prevalence and patterns of non-relapse mortality vary across the approved CAR T-cell products
Authors
- T. Melchardt
- B. Schöpf
- A. Egle
- M. Leisch
Institutions
- Paracelsus Medical University (AT)
Publication Details
- Journal
- Blood Immunology & Cellular Therapy
- Published
- 2026-01-19
- DOI
- https://doi.org/10.1016/j.bict.2026.100032
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00